The Potential Role of Pharmacogenomic and Genomic in the Adjuvant Treatment of Early Stage Non Small Cell Lung Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5488|9|4|252-262

ISSN： 1389-2029

Source： Current Genomics, Vol.9, Iss.4, 2008-06, pp. : 252-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Patents for Predictive and Prognostic Biomarkers in Non-Small-Cell Lung Cancer

By  

Recent Patents on Biomarkers, Vol. 1, Iss. 2, 2011-05 ,pp. : 119-138

Bentham Science Publishers

Access to resources Recommend Favorite

Induction of Multiple Programmed Cell Death Pathways by IFN- in Human Non-Small-Cell Lung Cancer Cell Lines

By Zhang H.   Koty P.P.   Mayotte J.   Levitt M.L.  

Experimental Cell Research, Vol. 247, Iss. 1, 1999-02 ,pp. : 133-141

Elsevier

Access to resources Recommend Favorite

Effects of Carvacrol on a Human Non-Small Cell Lung Cancer (NSCLC) Cell Line, A549

By Koparal A. Tansu   Zeytinoglu Melih  

Cytotechnology, Vol. 43, Iss. 1-3, 2003-01 ,pp. : 149-154

Springer Publishing Company

Access to resources Recommend Favorite

Camptothecin-induced apoptosis in non-small cell lung cancer is independent of cyclooxygenase expression

By Sánchez-Alcázar J. A.  

Apoptosis, Vol. 8, Iss. 6, 2003-12 ,pp. : 639-647

Springer Publishing Company

Access to resources Recommend Favorite

HLA-A Locus-Restricted and Tumor-Specific CTLs in Tumor-Infiltrating Lymphocytes of Patients with Non-Small Cell Lung Cancer

By Seki N.   Hoshino T.   Kikuchi M.   Hayashi A.   Itoh K.  

Cellular Immunology, Vol. 175, Iss. 2, 1997-02 ,pp. : 101-110

Academic Press

Access to resources Recommend Favorite